Institute of Automatic Control, RWTH Aachen, Aachen, Germany.
Institute of Applied Medical Engineering, RWTH Aachen University, Aachen, Germany.
Biomed Tech (Berl). 2022 Sep 13;67(6):461-470. doi: 10.1515/bmt-2021-0379. Print 2022 Dec 16.
Bioreactors are important tools for the pre-conditioning of tissue-engineered heart valves. The current state of the art mostly provides for timed, physical and biochemical stimulation in the bioreactor systems according to standard protocols (SOP). However, this does not meet to the individual biological variability of living tissue-engineered constructs. To achieve this, it is necessary to implement (i) sensory systems that detect the actual status of the implant and (ii) controllable bioreactor systems that allow patient-individualized pre-conditioning. During the maturation process, a pulsatile transvalvular flow of culture medium is generated within the bioreactor. For the improvement of this conditioning procedure, the relationship between the mechanical and biochemical stimuli and the corresponding tissue response has to be analyzed by performing reproducible and comparable experiments. In this work, a technological framework for maturation experiments of tissue-engineered heart valves in a pulsating bioreactor is introduced. The aim is the development of a bioreactor system that allows for continuous control and documentation of the conditioning process to increase reproducibility and comparability of experiments. This includes hardware components, a communication structure and software including online user communication and supervision. Preliminary experiments were performed with a tissue-engineered heart valve to evaluate the function of the new system. The results of the experiment proof the adequacy of the setup. Consequently, the concept is an important step for further research towards controlled maturation of tissue-engineered heart valves. The integration of molecular and histological sensor systems will be the next important step towards a fully automated, self-controlled preconditioning system.
生物反应器是组织工程心脏瓣膜预处理的重要工具。目前的技术大多根据标准协议 (SOP) 在生物反应器系统中提供定时、物理和生化刺激。然而,这并不能满足活组织工程构建体的个体生物学变异性。为了实现这一点,有必要实施 (i) 能够检测植入物实际状态的传感系统和 (ii) 允许患者个体化预处理的可控生物反应器系统。在成熟过程中,生物反应器内会产生脉动跨瓣膜培养基流。为了改进这种预处理程序,必须通过进行可重复和可比的实验来分析机械和生化刺激与相应组织反应之间的关系。在这项工作中,引入了一种在脉动生物反应器中进行组织工程心脏瓣膜成熟实验的技术框架。目的是开发一种生物反应器系统,允许连续控制和记录预处理过程,以提高实验的可重复性和可比性。这包括硬件组件、通信结构和软件,包括在线用户通信和监督。初步实验使用组织工程心脏瓣膜进行,以评估新系统的功能。实验结果证明了该设置的充分性。因此,该概念是朝着组织工程心脏瓣膜受控成熟进一步研究的重要步骤。分子和组织学传感器系统的集成将是朝着全自动、自我控制预处理系统迈出的下一步。